NCT03670940

Brief Summary

The etiology of bronchiectasis, known as permanent, abnormal, and localized development of bronchi, varies. However, most of them are responsible for infections during childhood. The prevalence of bronchiectasis is particularly high in advanced COPD patients. This phenomenon, called COPD-bronchiectasis overlap syndrome, affects the clinic of COPD patients negatively. In this study; bronchiectasis in respiratory function, exercise capacity, dyspnoea and quality of life in COPD patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2015

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 12, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 14, 2018

Completed
Last Updated

September 14, 2018

Status Verified

September 1, 2018

Enrollment Period

3.2 years

First QC Date

September 12, 2018

Last Update Submit

September 13, 2018

Conditions

BronchiectasisCopd

Outcome Measures

Primary Outcomes (1)

  • Exercise capacity

    six minute walk test

    15 minutes

Secondary Outcomes (3)

  • Dyspnea Severity

    5 minutes

  • Lung Function

    20 minutes

  • Health Related Quality of Life

    25 minutes

Study Arms (2)

COPD patients

COPD patients without bronchiectasis

COPD and bronchiectasis patients

COPD patients with bronchiectasis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

COPD patients with and without bronchiectasis.

You may qualify if:

  • above 18 years old
  • clinically stable

You may not qualify if:

  • other respiratory disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

BronchiectasisPulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof.

Study Record Dates

First Submitted

September 12, 2018

First Posted

September 14, 2018

Study Start

January 1, 2015

Primary Completion

March 1, 2018

Study Completion

April 1, 2018

Last Updated

September 14, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will not share